Nov 15 (Reuters) - Masimo Corp , a maker of non-invasive patient monitoring products, told U.S. regulators that it received allegations about the safety and efficacy of its hemoglobin testing products ...

NEUCHATEL, Switzerland--(BUSINESS WIRE)--Masimo (NASDAQ: MASI) announced today the full market release outside the U.S. of the Pronto ® Pulse CO-Oximeter ® with Next Generation SpHb ® Spot Check ...

Noting that in this area of care it is “essential to remain informed by the latest evidence,” the ESAIC, which has pledged to revisit its perioperative blood management guidelines at least every five ...

Now Available for Both Cerebral and Somatic Applications and for All Patient Populations, O3’s Delta Hemoglobin Parameters Offer Clinicians Additional Insight Into Changes in Tissue Oxygen Saturation ...